G-quadruplexes: a promising target for cancer therapy

N Kosiol, S Juranek, P Brossart, A Heine, K Paeschke - Molecular Cancer, 2021 - Springer
DNA and RNA can fold into a variety of alternative conformations. In recent years, a
particular nucleic acid structure was discussed to play a role in malignant transformation and …

Glutathione-mediated conjugation of anticancer drugs: an overview of reaction mechanisms and biological significance for drug detoxification and bioactivation

A Potęga - Molecules, 2022 - mdpi.com
The effectiveness of many anticancer drugs depends on the creation of specific metabolites
that may alter their therapeutic or toxic properties. One significant route of biotransformation …

[HTML][HTML] Acridine as an anti-tumour agent: a critical review

P Varakumar, K Rajagopal, B Aparna, K Raman… - Molecules, 2022 - mdpi.com
This review summarized the current breakthroughs in the chemistry of acridines as anti-
cancer agents, including new structural and biologically active acridine attributes. Acridine …

Nanoparticles: attractive tools to treat colorectal cancer

NK Younis, R Roumieh, EP Bassil… - Seminars in Cancer …, 2022 - Elsevier
Colorectal Cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
Despite the notable advances achieved over the last few decades, CRC remains a hard-to …

Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells

J Pilch, P Kowalik, A Kowalczyk, P Bujak… - International Journal of …, 2022 - mdpi.com
Targeted drug delivery by nanocarriers molecules can increase the efficiency of cancer
treatment. One of the targeting ligands is folic acid (FA), which has a high affinity for the folic …

pH-responsive drug delivery nanoplatforms as smart carriers of unsymmetrical bisacridines for targeted cancer therapy

J Pilch, A Potęga, A Kowalczyk, A Kasprzak, P Kowalik… - Pharmaceutics, 2023 - mdpi.com
Selective therapy and controlled drug release at an intracellular level remain key challenges
for effective cancer treatment. Here, we employed folic acid (FA) as a self-navigating …

Quantum dots as a good carriers of unsymmetrical bisacridines for modulating cellular uptake and the biological response in lung and colon cancer cells

J Pilch, P Kowalik, P Bujak, AM Nowicka, E Augustin - Nanomaterials, 2021 - mdpi.com
Nanotechnology-based drug delivery provides a promising area for improving the efficacy of
cancer treatments. Therefore, we investigate the potential of using quantum dots (QDs) as …

An overview of acridine analogs: Pharmacological significance and recent developments

G Sabarees, GP Tamilarasi… - Current Medicinal …, 2024 - ingentaconnect.com
The clinical effectiveness of the available anticancer drugs has been reduced due to the
development of drug resistance and serious adverse effects, which have restricted …

[HTML][HTML] Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects

ZQ Han, LN Wen - World Journal of Gastrointestinal Oncology, 2023 - ncbi.nlm.nih.gov
Genomic instability and inflammation are considered to be two enabling characteristics that
support cancer development and progression. G-quadruplex structure is a key element that …

The interactions of monomeric acridines and unsymmetrical bisacridines (UAs) with DNA duplexes: an insight provided by NMR and MD studies

T Laskowski, M Kosno, W Andrałojć, JE Frackowiak… - Scientific Reports, 2023 - nature.com
Members of a novel class of anticancer compounds, exhibiting high antitumor activity, ie the
unsymmetrical bisacridines (UAs), consist of two heteroaromatic ring systems. One of the …